Clear Exfoliating Solution

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne, specifically for clearing breakouts, unclogging and minimizing pores, and fading red marks associated with acne lesions.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be covered with a thin layer of the medication one to three times daily. It is recommended to initiate treatment with one application per day. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily.

To minimize the risk of excessive drying or irritation of the skin, if bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day. Careful monitoring of the skin's response is advised to ensure optimal therapeutic outcomes while minimizing adverse effects.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In cases where irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. This precaution is critical to ensure patient safety and appropriate management of potential toxicity.

Side Effects

Patients should be aware that this product is intended for external use only. The use of this topical medication may lead to skin irritation and dryness, particularly if it is used concurrently with another topical acne treatment. In such cases, if irritation occurs, it is recommended that only one topical acne medication be used at a time to minimize the risk of adverse reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Exfoliating Solution (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

When using this product, pediatric patients may experience skin irritation or dryness, particularly if used concurrently with other topical acne medications. It is advised to use only one topical acne treatment at a time to minimize the risk of irritation.

To mitigate excessive drying of the skin, it is recommended to initiate treatment with one application daily. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. If significant dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day.

Parents and caregivers should monitor for any signs of skin irritation and consult a healthcare provider if such symptoms develop or worsen.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

The product is not specifically contraindicated in pregnancy; however, caution is advised when prescribing to pregnant patients. Currently, there are no explicit statements regarding the risk to the fetus or specific safety concerns during pregnancy. Additionally, the prescribing information does not provide any dosage modifications for pregnant individuals. There are no special precautions outlined for the use of this product during pregnancy. Healthcare professionals should weigh the potential benefits against any unknown risks when considering this product for women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental ingestion.

Storage and Handling

The product is supplied in packaging that ensures its integrity and safety. It should be stored at room temperature, away from direct light exposure to maintain its efficacy. It is essential to keep the product out of the reach of children to prevent accidental ingestion. Once opened, the product must be discarded to ensure safety and effectiveness.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a healthcare professional. If bothersome dryness or peeling occurs, it is advised to reduce the frequency of application to once a day or every other day.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. Patients are also advised to discontinue use and consult a doctor if skin irritation occurs or worsens. It is important to note that the likelihood of skin irritation and dryness increases when using this product concurrently with other topical acne medications; therefore, patients should limit the use to one topical acne treatment at a time.

Drug Information (PDF)

This file contains official product information for Clear Exfoliating Solution, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)